E/e'/LVEDVi

Biomarker

1 paper

  • Human trial1

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months
European Heart Journal Cardiovascular Pharmacotherapy

Dapagliflozin did not improve heart relaxation in small trial

A heart-relaxation measure stayed at 6.2 with dapagliflozin, versus 6.6 to 6.7 with placebo, in a 32-person randomised trial.A heart-relaxation measure stayed at 6.2 with dapagliflozin, versus 6.6 to 6.7 with placebo, in a 32-person randomised trial.

Randomised trial in 32 peopleDapagliflozin